117 related articles for article (PubMed ID: 8889055)
21. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
22. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
23. Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?
Poirier B; Variot P; Delourme P; Maurin J; Morgeaux S
Vaccine; 2010 Feb; 28(7):1796-802. PubMed ID: 20018270
[TBL] [Abstract][Full Text] [Related]
24. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
Miceli G; Torroba JE; Diaz AM
Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
[TBL] [Abstract][Full Text] [Related]
25. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting antibody production against avian reovirus protein sigmaA.
Lin YL; Shen JH; Lee LH
J Virol Methods; 2006 Sep; 136(1-2):71-7. PubMed ID: 16730382
[TBL] [Abstract][Full Text] [Related]
27. [The phenomenon of "early and stimulated death" in mice infected and then vaccinated against rabies].
Bijlenga G; Ganeshwaran A; Joubert L; Lery L
Ann Rech Vet; 1988; 19(2):135-40. PubMed ID: 3415193
[TBL] [Abstract][Full Text] [Related]
28. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
[TBL] [Abstract][Full Text] [Related]
29. Development of a relative potency test using ELISA for human rabies vaccines.
Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
[TBL] [Abstract][Full Text] [Related]
30. Development of an in vitro potency test for tetanus vaccines: an immunoassay based on Hc fragment determination.
Prieur S; Broc S; Gal M; Poirier B; Fuchs F
Dev Biol (Basel); 2002; 111():37-46. PubMed ID: 12678223
[TBL] [Abstract][Full Text] [Related]
31. Isolation of a 14 kDa antigen from Taenia solium cyst fluid by HPLC and its evaluation in enzyme linked immunosorbent assay for diagnosis of porcine cysticercosis.
Assana E; Kanobana K; Tume CB; Zoli PA; Nguekam ; Geerts S; Berkvens D; Dorny P
Res Vet Sci; 2007 Jun; 82(3):370-6. PubMed ID: 17101161
[TBL] [Abstract][Full Text] [Related]
32. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
33. A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies.
Xu G; Weber P; Hu Q; Xue H; Audry L; Li C; Wu J; Bourhy H
Biologicals; 2007 Oct; 35(4):297-302. PubMed ID: 17276082
[TBL] [Abstract][Full Text] [Related]
34. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
Jallet C; Tordo N
J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
[TBL] [Abstract][Full Text] [Related]
35. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing.
Rooijakkers EJ; Uittenbogaard JP; Groen J; Osterhaus AD
J Virol Methods; 1996 Apr; 58(1-2):111-9. PubMed ID: 8783156
[TBL] [Abstract][Full Text] [Related]
36. A novel double-antigen sandwich enzyme-linked immunosorbent assay for Measurement of Antibodies against rabies virus.
Yang LM; Zhao LZ; Hu RL; Shi ZS; Liu WJ
Clin Vaccine Immunol; 2006 Aug; 13(8):966-8. PubMed ID: 16893999
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
38. Inactivated rabies vaccine control and release: use of an ELISA method.
Fournier-Caruana J; Poirier B; Haond G; Jallet C; Fuchs F; Tordo N; Perrin P
Biologicals; 2003 Mar; 31(1):9-16. PubMed ID: 12623055
[TBL] [Abstract][Full Text] [Related]
39. Reduction of the number of mice used for potency testing of human and animal rabies vaccines.
Bruckner L; Palatini M; Ackermann M; Müller HK; Kihm U
Experientia; 1988 Oct; 44(10):853-7. PubMed ID: 3181371
[TBL] [Abstract][Full Text] [Related]
40. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
Moore SM; Ricke TA; Davis RD; Briggs DJ
Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
